Arabic Arabic English English French French German German
dark

Petros Pharmaceuticals Completes Pilot Label Comprehension Study to Initiate Process for Stendra® Prescription Erectile Dysfunction Medication to Achieve Designation as an Over-the-Counter Treatment

Petros Pharmaceuticals, Inc. today announced it has completed a small label comprehension pilot study, the first step in a process to obtain over the counter status. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Over 486,000 Prescriptions Dispensed through ‘Wasfaty’ Service in Al-Ahsa

Next Post

Relief Therapeutics Reports that Collaboration Partner, NRx Pharmaceuticals, and Quantum Leap Announce Treatment of Severely Ill COVID-19 Patients with Aviptadil in the I-SPY COVID Trial

Related Posts
Total
0
Share